The U.S. Supreme Court delivered an unexpected setback to President Donald Trump’s administration Wednesday, October 21, rejecting an emergency request to eliminate gender-affirming healthcare for transgender people incarcerated in federal prisons.
The decision leaves in place a lower court injunction preventing the Federal Bureau of Prisons (BOP) from implementing restrictions that would terminate hormone therapy, gender-affirming surgeries, and accommodations for transgender prisoners.
According to NPR, the justices issued a brief order without explaining their reasoning. Conservative Justices Clarence Thomas and Samuel Alito indicated they would have granted the administration’s request.
A Policy Targeting Transgender Healthcare
The controversy stems from Trump’s January 2025 executive order directing federal agencies to recognize only two sexes and restrict government-funded gender-affirming treatments.
In February 2026, the BOP introduced policies eliminating hormone therapy, gender-affirming surgeries, and accommodations such as wigs, breast padding, binders, and clothing consistent with prisoners’ gender identities.
Three transgender prisoners challenged the restrictions through a class-action lawsuit, Kingdom v. Trump, arguing that abruptly withdrawing established medical treatments would cause significant physical and psychological harm.
In June, U.S. District Judge Royce Lamberth blocked the policy, finding that federal officials had failed to adequately justify abandoning decades of established medical practices.
The administration subsequently appealed, arguing that restrictions were necessary for institutional security and that gender-affirming treatments were medically disputed.
Thousands of Transgender Prisoners Affected
The American Civil Liberties Union estimates that more than 2,000 transgender people are currently held in federal custody.
The lawsuit represents approximately 1,000 prisoners diagnosed with gender dysphoria, including roughly 800 who have been prescribed hormone therapy.
Federal prisons have provided hormone treatment for gender dysphoria since at least 1992, according to attorneys representing the plaintiffs.
Advocates argue that discontinuing medically necessary treatment can increase depression, anxiety, and risks of self-harm, particularly among prisoners who cannot independently access healthcare.
An Unusual Victory, But Not the Final Word
Wednesday’s decision stands in sharp contrast to several recent Supreme Court actions allowing restrictions on transgender Americans, including limitations involving military service, identification documents, and healthcare for minors.
However, the ruling does not establish a permanent constitutional right to gender-affirming care in federal prisons. Instead, it preserves existing protections while the underlying lawsuit continues.
For transgender prisoners facing the possibility of losing essential medical treatment, that distinction matters.
The Trump administration’s broader campaign against transgender healthcare remains underway, but for now, the Supreme Court has refused to let federal officials turn off the medical care thousands of incarcerated transgender Americans depend upon.
